[1] The medication carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Alcohol, GLP-1 Therapy, and Hypoglycemia Risk Alcohol deserves special attention because it interacts directly with semaglutide's effects on blood glucose regulation
Many women begin semaglutide after breastfeeding ends, allowing full therapeutic benefit without lactation concerns
CVB has been reported to infect multiple human cell types associated with T1D, including primary islets, human pluripotent stem cell-derived islets, ductal cells, thymic epithelial cells, thymic fetal cells, and human PBMCs (115, 140149)
Safe use of GLP-1 therapy hinges on close medical supervision and frequent kidney function tests
The funding for the Mayo Clinic bipolar disorder study is provided by Marriott Foundation